Isagani (Gani) M. Chico, M.D.

VP and Global Head for Oncology, Fortrea

Isagani (Gani) M. Chico, M.D., has more than 35 years’ experience in oncology clinical drug development from small and medium size biotechnology companies, CROs and the FDA, focused on planning and execution of global oncology clinical development projects from early phase to post approval.

Gani leads a team of more than 50 oncology physicians across Europe, North America, Latin America and Asia. The oncology medical team executes program and study level medical oversight that span early phase clinical development through late-phase and post-marketing studies.

Talk to Gani about these topics and more:

Oncology clinical trials (early phase to post approval)
Oncology medical affairs
Pharmaceutical, academic and regulatory interactions

Ready to Connect?

Would you like to invite a life science expert to participate in your next piece, program, panel, or partnership? Our team is standing by to help connect you to the right source and topic:

About Fortrea

Fortrea is a provider of comprehensive Phase I-IV clinical trial management, clinical pharmacology and consulting services. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life-changing therapies to patients. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.